We are live on !
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
Turnover
15.26%
1-Year Est. Return
41.24%
This Quarter Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
(+2.4%)
Cap. Flow
-$7.07B
Cap. Flow % of AUM
Cap. Flow %
-10.23%
Top 10 Holdings %
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132
Avg Time Held
6.4
years
Top 10 Avg Time Held
5.6
years
Top 20 Avg Time Held
5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$199M |
| 2 |
Sandisk
SNDK
|
+$197M |
| 3 |
Genuine Parts
GPC
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$134M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$76.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$876M |
| 2 |
NVIDIA
NVDA
|
+$678M |
| 3 |
Apple
AAPL
|
+$472M |
| 4 |
Microsoft
MSFT
|
+$341M |
| 5 |
Micron Technology
MU
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.21% |
| 2 | Miscellaneous | 27.25% |
| 3 | Industrials | 6.93% |
| 4 | Consumer Staples | 6.67% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Evolent Health
EVH
$485M
| $81.3K | ﹤0.01% |
15,001
-1,173
| -7% | -$4.5K |
2020 Q4
22 quarters
|
|
1802
Pacific Biosciences
PACB
$877M
| $79.3K | ﹤0.01% |
47,184
-6,351
| -12% | -$9.23K |
2013 Q2
52 quarters
|
|
1803
Opko Health
OPK
$1.22B
| $79.1K | ﹤0.01% |
52,766
-87,892
| -62% | -$112K |
2016 Q4
38 quarters
|
|
1804
C4 Therapeutics
CCCC
$421M
| $78.9K | ﹤0.01% |
+16,895
| New | +$57.8K |
2026 Q2
0 quarters
|
|
1805
Rackspace Technology
RXT
$726M
| $78.7K | ﹤0.01% |
12,055
-388
| -3% | -$1.51K |
2024 Q3
7 quarters
|
|
1806
AbCellera Biologics
ABCL
$4.31B
| $78.6K | ﹤0.01% |
10,011
-3,551
| -26% | -$17.4K |
2021 Q4
18 quarters
|
|
1807
Lexicon Pharmaceuticals
LXRX
$650M
| $78.2K | ﹤0.01% |
+32,588
| New | +$63.5K |
2026 Q2
0 quarters
|
|
1808
Bit Digital
BTBT
$337M
| $77.5K | ﹤0.01% |
43,081
-3,576
| -8% | -$6.3K |
2023 Q4
10 quarters
|
|
1809
Cerus
CERS
$488M
| $76.1K | ﹤0.01% |
26,048
-725
| -3% | -$1.76K |
2013 Q2
52 quarters
|
|
1810
Aquestive Therapeutics
AQST
$522M
| $75.9K | ﹤0.01% |
18,254
-1,985
| -10% | -$8.35K |
2024 Q3
7 quarters
|
|
1811
Satellogic
SATL
$578M
| $71.4K | ﹤0.01% |
12,486
+429
| +4% | +$3.14K |
2025 Q2
4 quarters
|
|
1812
AH Realty Trust
AHRT
$448M
| $71.3K | ﹤0.01% |
10,067
-1,535
| -13% | -$9.9K |
2023 Q2
12 quarters
|
|
1813
Cytek Biosciences
CTKB
$788M
| $70.5K | ﹤0.01% |
15,925
-2,291
| -13% | -$9.8K |
2022 Q1
17 quarters
|
|
1814
Brandywine Realty Trust
BDN
$488M
| $70.5K | ﹤0.01% |
22,251
-2,721
| -11% | -$8.18K |
2021 Q2
20 quarters
|
|
1815
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$921M
| $69.7K | ﹤0.01% |
30,715
-1,524
| -5% | -$2.84K |
2023 Q2
12 quarters
|
|
1816
Vaalco Energy
EGY
$675M
| $69.4K | ﹤0.01% |
13,657
-1,356
| -9% | -$7.81K |
2022 Q4
14 quarters
|
|
1817
iHeartMedia
IHRT
$240M
| $69.2K | ﹤0.01% |
16,141
-1,499
| -8% | -$6.65K |
2020 Q4
22 quarters
|
|
1818
Myriad Genetics
MYGN
$629M
| $69.2K | ﹤0.01% |
12,111
-1,239
| -9% | -$5.62K |
2013 Q2
52 quarters
|
|
1819
Solid Power
SLDP
$454M
| $68.8K | ﹤0.01% |
26,568
+1,017
| +4% | +$3.14K |
2022 Q3
15 quarters
|
|
1820
Ocugen
OCGN
$255M
| $68.5K | ﹤0.01% |
+44,746
| New | +$68K |
2026 Q2
0 quarters
|
|
1821
Ur-Energy
URG
$355M
| $67.8K | ﹤0.01% |
+49,847
| New | +$81.3K |
2026 Q2
0 quarters
|
|
1822
Prime Medicine
PRME
$945M
| $67.3K | ﹤0.01% |
18,243
-4,725
| -21% | -$15.7K |
2023 Q4
10 quarters
|
|
1823
New Era Energy & Digital Inc
NUAI
$393M
| $67.1K | ﹤0.01% |
+10,517
| New | +$51.1K |
2026 Q2
0 quarters
|
|
1824
FTAI Infrastructure
FIP
$326M
| $66.9K | ﹤0.01% |
14,424
-1,468
| -9% | -$7.31K |
2023 Q2
12 quarters
|
|
1825
Achieve Life Sciences
ACHV
$694M
| $66.6K | ﹤0.01% |
+10,192
| New | +$48.6K |
2026 Q2
0 quarters
|
|
Similar funds
ProShare Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.
- ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
- ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
- ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
- ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
- ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
- ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
- ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.